BeiGene Ltd - ADR

BGNE

Market Cap$14.21B

Close$

Compare BeiGene Ltd - ADR

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
BeiGene Ltd - ADR	-16.1	0%	-25%	6.1	0.3
Market Avg	58.9	1.29%	29%	-	1
Healthcare Avg	66.3	1.31%	15%	-	0.9

$150.03

Current Fair Value

2.3% downside

Overvalued by 2.3% based on the discounted cash flow analysis.

Share Statistics

Market cap	$14.21 Billion
Enterprise Value	$11.92 Billion
Dividend Yield	$0.0 (0.0%)
Earnings per Share	$-8.45
Beta	0.0
Outstanding Shares	95,639,914
Avg 30 Day Volume	178,260

Return

Return on Equity	-
Return on Assets	-
Return on Invested Capital	-

Valuation & Multiples

P/E Ratio	-16.11
PEG	97.27
Price to Sales	6.14
Price to Book Ratio	4.27
Enterprise Value to Revenue	4.85
Enterprise Value to EBIT	-9.87
Enterprise Value to Net Income	-14
Total Debt to Enterprise	0.07
Debt to Equity	0.25

Revenue Sources

No data

ESG Score

No data

About BeiGene Ltd

CEO: John Oyler